Amid ongoing economic challenges and a continued debate about the best uses of healthcare dollars in private and public healthcare plans, the National Association of Chain Drug Stores on Wednesday called for a renewed focus on the value of community pharmacy.
The National Advertising Division of the Council of Better Business Bureaus earlier this month determined that Rexall Sundown has supported claims regarding the company’s Osteo Bi-Flex glucosamine HCL and vitamin D3 dietary supplement.
Perrigo on Wednesday announced that its closing date to complete the acquisition of Paddock Labs — a generic pharmaceutical and specialty over-the-counter products manufacturer — has been delayed by an extended Federal Trade Commission review.
Adding an investigational drug for Type 2 diabetes to the common generic drug metformin helped control blood sugar in patients who could not control their blood sugar with metformin alone, according to results of a late-stage clinical study.
Important safety information often is missing from drug labels, while some pharmacies don’t include medication guides required by the federal government, according to a new investigation by Consumer Reports.
McNeil Consumer Healthcare on Tuesday initiated another recall at the retail level of one product lot (60,912 bottles) of Tylenol extra strength caplets in 225-count bottles because of a small number of odor reports, including a musty, moldy odor.
Smarticle Industries on Wednesday announced the launch of StingOut, a product designed to soothe the sting of the box jellyfish and the Portuguese man-of-war, which has been found in waters from Texas and Florida to the northeastern United States.
An investigational Sanofi drug for diabetes works at least as well as a similar treatment already on the market, and results in less abnormally low blood sugar, according to late-stage clinical trial results presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego this past weekend.
The Obama administration recently called on the public for ideas to streamline federal regulations. In response, the National Association of Chain Drug Stores has sent its suggestion to the Food and Drug Administration.
A new study indicated that two insulin products made by French drug maker Sanofi lower blood-glucose levels to a greater extent than premixed insulin, and with improvements in quality of life and less hypoglycemia.